Also called personalized medicine, this evolving field makes use of an individual’s genes, lifestyle, environment and other factors to identify unique disease risks and guide treatment decision-making.
Masimo's MightySat Medical is the first FDA-cleared pulse oximeter available to consumers without a prescription, which could disrupt the market for the notoriously inaccurate at-home devices.
MediView’s technologies utilize AR to provide clinicians with 3D “X-ray vision” guidance during minimally invasive procedures and surgeries, while also offering remote collaboration.
Productive communication between doctors and patients can be difficult to achieve. However, a team of researchers has proposed several ways in which AI can help.
Access to care at the U.S. Department of Veterans Affairs (VA) has improved since 2014, compared to the stagnant wait times in the private sector, according to new research published inJAMA Network Open.
Day Zero Diagnostics has raised $8.6 million in a Series A funding round to further develop a system that uses genome sequencing and machine learning to better diagnose infectious diseases.
Ruth Porat, chief financial officer of Google parent company Alphabet, said the company is making progress in breast cancer care thanks to AI, according to a report by CNBC.
Rural hospitals in the United States have been closing at a rapid clip over the last several years––nearly 100 since 2010, according to one estimate. Another 600-plus rural hospitals are at risk of closing, with many clustered in the 14 remaining states that have not expanded Medicaid under the Affordable Care Act, according to the Pew Institute.
Researchers have trained an AI system to interpret and prioritize chest X-rays based on urgent and critical findings, according to a study published in Radiology.
Princeton researchers have developed a machine-learning method that could reduce the number of tests and improve the timing of critical treatments for intensive care unit patients.
Verily, a subsidiary of Google parent company Alphabet, has received FDA clearance for the electrocardiogram (ECG) feature in its Study Watch, the company announced.
